Perfect Medical Industry Co., Ltd. (TPEX:6543)
Taiwan
· Delayed Price · Currency is TWD 26.70
-0.95 (-3.44%)
Mar 10, 2026, 10:06 AM CST
Perfect Medical Industry Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 737.27 | 744.16 | 734.13 | 677.04 | 724.61 | 807.76 | Upgrade
|
| Revenue Growth (YoY) | -3.07% | 1.36% | 8.43% | -6.57% | -10.29% | 19.54% | Upgrade
|
| Cost of Revenue | 515.46 | 505.96 | 533.58 | 542.63 | 515.08 | 555.03 | Upgrade
|
| Gross Profit | 221.81 | 238.19 | 200.56 | 134.41 | 209.53 | 252.73 | Upgrade
|
| Selling, General & Admin | 131.53 | 137.56 | 134.78 | 123.61 | 145.44 | 114.68 | Upgrade
|
| Research & Development | 11.96 | 9.3 | 7.4 | 7.12 | 5.58 | 7.57 | Upgrade
|
| Operating Expenses | 143.47 | 146.95 | 142.2 | 130.75 | 151.28 | 123.02 | Upgrade
|
| Operating Income | 78.35 | 91.24 | 58.36 | 3.65 | 58.24 | 129.71 | Upgrade
|
| Interest Expense | -4.69 | -3.72 | -4.37 | -4.46 | -2.96 | -2.05 | Upgrade
|
| Interest & Investment Income | 5.14 | 5.42 | 3.33 | 1.03 | 1.6 | 2.26 | Upgrade
|
| Currency Exchange Gain (Loss) | 4.36 | 13.42 | 7.34 | 13.18 | 3.93 | 1.9 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.02 | 4.9 | 3.02 | 3.33 | 1.52 | 1.18 | Upgrade
|
| EBT Excluding Unusual Items | 86.19 | 111.26 | 67.67 | 16.73 | 62.33 | 133 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.09 | 0.4 | 1.19 | 1.18 | 0.19 | 0.44 | Upgrade
|
| Asset Writedown | - | -4.28 | -14.61 | - | - | - | Upgrade
|
| Other Unusual Items | 0.08 | - | - | 0.06 | - | - | Upgrade
|
| Pretax Income | 86.36 | 107.38 | 54.25 | 17.98 | 62.52 | 133.44 | Upgrade
|
| Income Tax Expense | 13.89 | 18.26 | 14.16 | 3.71 | 23.75 | 32.75 | Upgrade
|
| Net Income | 72.48 | 89.12 | 40.09 | 14.27 | 38.77 | 100.69 | Upgrade
|
| Net Income to Common | 72.48 | 89.12 | 40.09 | 14.27 | 38.77 | 100.69 | Upgrade
|
| Net Income Growth | 3.18% | 122.31% | 180.93% | -63.20% | -61.49% | 176.31% | Upgrade
|
| Shares Outstanding (Basic) | 53 | 49 | 46 | 44 | 41 | 40 | Upgrade
|
| Shares Outstanding (Diluted) | 55 | 51 | 46 | 44 | 41 | 42 | Upgrade
|
| Shares Change (YoY) | 18.54% | 11.20% | 3.98% | 8.91% | -2.73% | 4.39% | Upgrade
|
| EPS (Basic) | 1.37 | 1.81 | 0.88 | 0.32 | 0.95 | 2.49 | Upgrade
|
| EPS (Diluted) | 1.31 | 1.74 | 0.87 | 0.32 | 0.95 | 2.40 | Upgrade
|
| EPS Growth | -13.25% | 100.00% | 171.88% | -66.32% | -60.44% | 163.82% | Upgrade
|
| Free Cash Flow | 22.39 | 45.84 | 85.17 | 52.87 | -98.89 | 0.49 | Upgrade
|
| Free Cash Flow Per Share | 0.41 | 0.90 | 1.85 | 1.20 | -2.43 | 0.01 | Upgrade
|
| Dividend Per Share | 0.870 | 1.500 | 0.700 | 0.370 | 0.316 | 1.453 | Upgrade
|
| Dividend Growth | -34.59% | 114.29% | 89.19% | 17.13% | -78.25% | 114.28% | Upgrade
|
| Gross Margin | 30.09% | 32.01% | 27.32% | 19.85% | 28.92% | 31.29% | Upgrade
|
| Operating Margin | 10.63% | 12.26% | 7.95% | 0.54% | 8.04% | 16.06% | Upgrade
|
| Profit Margin | 9.83% | 11.98% | 5.46% | 2.11% | 5.35% | 12.47% | Upgrade
|
| Free Cash Flow Margin | 3.04% | 6.16% | 11.60% | 7.81% | -13.65% | 0.06% | Upgrade
|
| EBITDA | 132.19 | 141.78 | 108 | 51.54 | 100.5 | 164.57 | Upgrade
|
| EBITDA Margin | 17.93% | 19.05% | 14.71% | 7.61% | 13.87% | 20.37% | Upgrade
|
| D&A For EBITDA | 53.84 | 50.54 | 49.64 | 47.89 | 42.25 | 34.87 | Upgrade
|
| EBIT | 78.35 | 91.24 | 58.36 | 3.65 | 58.24 | 129.71 | Upgrade
|
| EBIT Margin | 10.63% | 12.26% | 7.95% | 0.54% | 8.04% | 16.06% | Upgrade
|
| Effective Tax Rate | 16.08% | 17.00% | 26.11% | 20.62% | 37.98% | 24.54% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.